Found: 8
Select item for more details and to access through your institution.
The ATR inhibitor elimusertib exhibits anti‐lymphoma activity and synergizes with the PI3K inhibitor copanlisib.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. 191, doi. 10.1111/bjh.19218
- By:
- Publication type:
- Article
ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 2, p. 244, doi. 10.1111/bjh.19018
- By:
- Publication type:
- Article
Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 2, p. 399, doi. 10.3390/jcm12020399
- By:
- Publication type:
- Article
Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1912, doi. 10.3390/cancers12071912
- By:
- Publication type:
- Article
The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax.
- Published in:
- Cancers, 2019, v. 11, n. 6, p. 775, doi. 10.3390/cancers11060775
- By:
- Publication type:
- Article
The Role of FLI1 in mRNA Splicing and rRNA Processing of Diffuse Large B Cell Lymphoma (DLBCL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S373, doi. 10.1016/j.clml.2017.07.212
- By:
- Publication type:
- Article
ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02159-3
- By:
- Publication type:
- Article
Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma.
- Published in:
- EJHaem, 2022, v. 3, n. 3, p. 764, doi. 10.1002/jha2.535
- By:
- Publication type:
- Article